Traditionally, the amount of experience and effort required to process mitochondrial DNA (mtDNA) has restricted analysis to the mutation-rich control region. Verogen next-generation sequencing technology empowers laboratories to analyze the control region or the whole mitochondrial genome with equivalent effort and improved software that simplifies and accelerates complex analysis. The result is an efficient, scalable workflow offering improved data quality and resolution for challenging samples.
In this recorded presentation, Verogen Chief Scientific Officer Cydne Holt and Director of Product Management Swathi Kumar provide a review of the specifications and performance of the ForenSeq mtDNA Whole Genome Kit, including data on sensitivity, inhibitor resistance, and coverage of real samples, such as bones and teeth.
Featuring
Cydne Holt
Verogen Chief Scientific Officer Verogen
Swathi Kumar
Director of Product Management Verogen